FDA Recalls TUMS Antacid Tablets for Glass Mineral Wool Contamination
GlaxoSmithKline is recalling TUMS Antacid tablets (Lot HA7G, expiration 8/31/2027) due to contamination with glass mineral wool. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification with a foreign substance hazard present. No illnesses or injuries reported in the source, but the contamination presents a risk of harm (choking and potential GI tract injury) qualifying as a risk-of-harm product.
Plain-English summary
GlaxoSmithKline Consumer Healthcare Holdings LLC is recalling TUMS Antacid tablets containing calcium carbonate 1000 mg in peppermint flavor, packaged as 12-count rolls. The recall applies specifically to Lot HA7G with an expiration date of 8/31/2027.
The tablets may contain glass mineral wool, a foreign substance that could pose a risk of injury to consumers, including choking hazard.
The affected product was distributed nationwide within the United States. Consumers should discontinue use of the recalled product and consult their healthcare provider if they have concerns about exposure.
The recalled product
- Product
- TUMS (CALCIUM CARBONATE)
- Brand
- TUMS
- Manufacturer
- GlaxoSmithKline Consumer Healthcare Holdings LLC
- Category
- Drug — Antacid
- Hazard
- glass-contamination
- foreign-substance
- choking
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: HA7G
- Exp. Date 8/31/2027
UPCs (1)
- 307660746805
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TUMS
- HighTUMS Antacid Recalled for Glass Mineral Wool Contamination
FDA (Drugs) · 2023-11-08
- HighTUMS antacid tablets recalled due to glass mineral wool contamination
FDA (Drugs) · 2023-11-08
- HighTUMS Antacid Recalled for Glass Mineral Wool Contamination
FDA (Drugs) · 2023-11-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01